Ophthalmology · Gainesville, GA
NPI
1194082479
Since 2012
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1485 Jesse Jewell Pkwy NE, Ste 100
Gainesville, GA, 30501
Phone (770) 534-1711
Groups this clinician bills Medicare through
Medicare paid, 2024
$485K
6,246 services
Medicare patients, 2024
1,896
Average age 77
Drug cost, 2024
$1.0M
5,673 prescriptions
Company payments, 2025
$968
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew W Hollar was code 92014 (ophthalmological e&m), 1,353 times for 1,348 patients. In total Matthew W Hollar billed 6,246 services in 38 codes, and Medicare paid $485K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 1,353 | 1,348 | $79.90 | $108K |
| 99214 Office E&M - Established | Office | 813 | 591 | $86.75 | $71K |
| 99213 Office E&M - Established | Office | 587 | 478 | $61.94 | $36K |
| 92133 Computerized Ophthalmic Imaging | Office | 554 | 519 | $24.03 | $13K |
| 92083 Vision, Hearing, and Speech Services | Office | 550 | 495 | $43.04 | $24K |
| 92134 Computerized Ophthalmic Imaging | Office | 384 | 326 | $26.97 | $10K |
| 92250 Angiography | Office | 372 | 369 | $24.71 | $9,192 |
| 66984 Cataract Surgery | Facility | 312 | 192 | $405.58 | $127K |
| 92136 Ultrasound - Nonspecific | Office | 306 | 195 | $28.94 | $8,856 |
| 83861 Clinical Chemistry | Office | 286 | 135 | $22.03 | $6,301 |
| 92020 Ophthalmological E&M | Office | 110 | 109 | $19.55 | $2,150 |
| 76514 Ultrasound - Nonspecific | Office | 96 | 95 | $7.36 | $707 |
| 66821 Cataract Surgery | Office | 83 | 68 | $252.37 | $21K |
| 92004 Ophthalmological E&M | Office | 81 | 81 | $93.41 | $7,566 |
| 83516 Immunoassay | Office | 79 | 40 | $11.30 | $893 |
By year: 2022 $466K for 6,501 services; 2023 $489K for 6,941 services; 2024 $485K for 6,246 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 286 | 135 | $22.03 | $6,301 |
| 83516 Immunoassay | 79 | 40 | $11.30 | $893 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew W Hollar prescribed most often to Medicare patients was Latanoprost, with 1,577 prescriptions and refills. In total Matthew W Hollar wrote 5,673 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,577 | 3,470 | 455 | $22K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 623 | 1,310 | 177 | $12K |
| Timolol Maleate Generic | 483 | 1,118 | 163 | $4,764 |
| Prednisolone Acetate Generic | 354 | 377 | 244 | $10K |
| Lumigan Bimatoprost | 293 | 601 | 86 | $167K |
| Brimonidine Tartrate Generic | 203 | 418 | 61 | $11K |
| Restasis Cyclosporine | 179 | 312 | 76 | $196K |
| Moxifloxacin Moxifloxacin Hcl | 167 | 170 | 103 | $3,544 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 165 | 168 | 124 | $1,697 |
| Xiidra Lifitegrast | 126 | 277 | 69 | $180K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 124 | 126 | 110 | $5,366 |
| Dorzolamide Hcl Generic | 106 | 204 | 33 | $1,696 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 90 | 151 | 28 | $15K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 90 | 115 | 17 | $38K |
| Cyclosporine Generic | 90 | 208 | 44 | $74K |
Brand drugs: 2,085 claims; generic drugs: 3,588 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew W Hollar $968 ($968 in general payments such as food, travel and fees) from 12 companies. The largest payer was Alcon Vision LLC with $503.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 18 | $503 |
| Dompe US, Inc. | 3 | $95.03 |
| Harrow Eye, LLC | 2 | $57.5 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $57.22 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $54.59 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $43.65 |
| Amgen Inc. AMGN | 2 | $36.37 |
| Abbvie Inc. ABBV | 1 | $32.38 |
| Biotissue Holdings Inc. | 1 | $28.02 |
| Rayner Intraocular Lenses Limited | 1 | $23.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.